XBIO: Xenetic Bio Sotuvga nisbatan narx

Xenetic Bio (XBIO) tovar belgisi

Xenetic Biosciences (XBIO) kompaniyasining kuchli ilmiy jamoasi moliyaviy risklarni minimallashtiradi va P/S bozor koeffitsiyenti ushbu barqarorlikni vizuallashtiradi, bunda 1.20 darajasi so'nggi qiymatlarni aks ettiradi. Xarajatlarni optimallashtirish sinovlarni tashqi CROlarga to'liq autsorsing qilishga asoslangan, XCART brendiga bo'lgan yuqori sodiqlik esa kapitalizatsiyani qo'llab-quvvatlaydi. Ushbu grafik haqiqiy bozor talabini kompaniyaning daromadlari bilan solishtiradi.

XBIO (Xenetic Biosciences) P/S multiplikatori tarixi 04.07.2022dan 17.11.2026gacha

Xenetic Bio (XBIO) kompaniyasining tahliliy kesimlari

Kompaniyaning umumiy tahlili:XBIO (xeneticbio.com)
Xenetic Biosciences Inc. brendining mahsuloti

Biznesning barqarorligini sotuvlar nisbatidagi narx (price-to-sales) koeffitsiyenti orqali baholash investorga yaratilgan mahsulotning bir birligi uchun xarajatni aniqlash imkonini beradi. Xenetic Biosciences (XBIO) kompaniyasining tekislangan P/S koeffitsiyentini tahlil qilish baholashning kelajakdagi muvaffaqiyatlarga kritik darajada bog'liqligini ko'rsatadi, chunki ishlanmalarning preklinik holati tufayli joriy sotuvlarning yo'qligi ushbu ko'rsatkichni o'ta beqaror va spekulyativ qiladi.

Xenetic Biosciences kimlar bilan raqobatlashadi

ONC - Sotuvga nisbatan narx|P/S multiplikatori HALO (Halozyme Therapeutics, Inc.)|Revolution Medicines (RVMD) - Sotuvga nisbatan narx|ascentage.com - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati CGON (cgoncology.com)|URGN: P/S multiplikatori|Bicara Therapeutics Inc (BCAX) - P/S multiplikatori|Narxning daromadga nisbati personalis.com|Kapitalizatsiyaning daromadga nisbati Erasca Corp (ERAS)|Kapitalizatsiyaning daromadga nisbati DCTH (Delcath)|Narx/daromad koeffitsiyenti Y-mAbs Therapeutics, Inc.|P/S multiplikatori AURA (Aura Biosciences Inc)|Bozor kapitallashuvining daromadga nisbati CADL|ARAY: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti sellaslifesciences.com SLS|ACTU (Actuate Therapeutics, Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati CTOR|Narxning daromadga nisbati TuHURA Biosciences Inc.|TARA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Fate Therapeutics (FATE)|Narx/daromad koeffitsiyenti Aadi Bioscience|Narxning daromadga nisbati TScan Therapeutics Inc TCRX|CSBR: Kapitalizatsiya va daromad nisbati|XBIT: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CVM (cel-sci.com)|OSTX: P/S multiplikatori|Sotuvga nisbatan narx Radiopharm Theranostics Ltd (RADX)|ARTV (Artiva) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati ANL (Adlai Nortye)|Narxning daromadga nisbati Veru Pharma (VERU)|P/S multiplikatori Tempest Tx (TPST)|Narxning daromadga nisbati xiliotx.com XLO|Enochian BioSciences - Narxning daromadga nisbati|Mural Oncology - P/S multiplikatori|KAPA - P/S multiplikatori|OnKure Therapeutics Inc (OKUR) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CytoMed|Narxning daromadga nisbati curis.com|Kapitalizatsiyaning daromadga nisbati Apollomics, Inc. (APLM)|P/S multiplikatori THAR|Advanced Biomed Corp - Kapitalizatsiya va daromad nisbati|Narxning daromadga nisbati Genprex GNPX|Narx/daromad koeffitsiyenti Calidi Bio (CLDI)|sunshinebiopharma.com - P/S multiplikatori|SLRX: Narxning daromadga nisbati|Purple Biotech (PPBT) - Narxning daromadga nisbati|AON - Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati BGNE|P/S multiplikatori Checkpoint Therapeutics Inc.|P/S multiplikatori ELEV|Kapitalizatsiyaning daromadga nisbati iCAD ICAD|P/S multiplikatori IKNA (Ikena Oncology, Inc.)|Bozor kapitallashuvining daromadga nisbati NTBL|Viracta Therapeutics, Inc. - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati MOR (MorphoSys Inc)|NAYA (NAYA Biosciences Inc) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Ascentage Pharma Group Ltd